Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Indian-Run Pharma Plant In Ukraine Destroyed In Russian Drone Attacks, 1 Killed
The Kusum group plant in Ukraine hit by Russian drones Summary is AI-generated, newsroom-reviewed A Kusum group pharma plant in Ukraine's Sumy was hit by Russian drones, killing one The main structure of the pharma plant was mostly destroyed in the…
Russian drones hit pharma warehouse owned by Indians, killed staffer: Ukraine
5 min read New Delhi Make us preferred source on Google Ukraine's President Volodymyr Zelenskyy said Sunday that Russia attacked a pharmaceutical warehouse in Sumy with drones. The Ukrainian embassy in Delhi identified it as belonging to Indian…
Indian-owned Kusum Pharma Plant in Ukraine attacked in Russian drone strike; 1 killed, several injured
A massive pharma plant in Ukraine belonging to India's Kusum Group came under attack by Russian drones, killing one person and leaving several injured. The main structure of the plant in Sumy's region has been mostly destroyed. Officials said…
M&T: Buy Reaffirmed, Despite Market Pullback, As Growth And Earnings Story Remain Strong
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Eli Lilly Just Announced Something Big. Here's What It Means for Investors.
Eli Lilly (LLY -0.61%) has been making the headlines for one particular reason over the last few years. It dominates in an area that has captured the general public's attention: weight loss drugs. Lilly sells injectable GLP-1 drugs Mounjaro and…
My friends are spouting conspiracy theories - what should I say? | Ask Annalisa Barbieri
Recently, I had a conversation with a friend who explained that her ill health was down to reasons I would describe as dubious. Taking certain supplements and changing her diet have significantly improved her health. Good for her. However, she was…
Lennart Jasch declares arrival as GC force with Le Tour de Langkawi overall victory, Matteo Malucelli claims stage 8 sprint to deliver three stage wins for 2026
On the final stage to Putrajaya, Matteo Malucelli (XDS Astana) sprinted to his third win in the 2026 edition of Le Tour de Langkawi while Lennart Jasch (Tudor Pro Cycling) finished off a stellar first run at team leadership by keeping his firm grip…
My 3 Favorite Ultra-High-Yield Dividend Stocks to Buy for October
Does a market environment with nagging inflation, Fed rate hikes, and geopolitical uncertainty make ultra-high-yield dividend stocks riskier? Not necessarily. Actually, the opposite could be true for certain stocks that offer exceptionally high…
Inside Track: Lessons From Past
Following Seshan's term, the rule of majority has always prevailed. On the rare occasion when two commissioners, the late Navin Chawla and SY Qureshi, concurred in 2009 against then-CEC N Gopalaswami's decision on serving a notice to Sonia Gandhi…
Exclusive | How Tanya Zuckerbrot lost her $40M diet empire to one troll, and the six year fight for justice
How does a fashion influencer with no medical or nutrition qualifications bring down a $40 million diet empire, with only a phone? Emily Gellis managed to do just that after accusing F-Factor dieting guru Tanya Zuckerbrot of poisoning people…
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Rating Raised to 'Hold' at Wall Street Zen
Tonix Pharmaceuticals (NASDAQ:TNXP - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a research note issued to investors on Sunday, Wall Street Zen reports. Pharma Frenzy:…
argenex SE (NASDAQ:ARGX) Receives Average Rating of 'Moderate Buy' from Analysts
argenex SE (NASDAQ:ARGX - Get Free Report) has received a consensus recommendation of 'Moderate Buy' from the twenty-four research firms that are currently covering the firm, MarketBeat reports. Five analysts have rated the stock with a hold…
Receive a Daily briefing on Pharma Industry News
Get Started